Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
2000-1-27
pubmed:abstractText
P75/AIRM1 is a recently identified surface molecule that belongs to the sialoadhesin family and displays homology with the myeloid cell antigen CD33. In lymphoid cells, p75/AIRM1 is confined to natural killer cells and mediates inhibition of their cytolytic activity. In this study, we show that p75/AIRM1 is also expressed by cells of the myelomonocytic cell lineage, in which it appears at a later stage as compared with CD33. In vitro proliferation and differentiation of cord blood-derived CD34(+) cells (induced by stem cell factor and granulocyte-macrophage colony-stimulating factor) were consistently inhibited by the addition of anti-p75/AIRM1 mAb. Engagement of CD33 led to inhibition in some experiments. A sharp decrease of cell proliferation/survival was detected in all three p75/AIRM1+ chronic myeloid leukemias analyzed when cultured in the presence of either anti-p75/AIRM1 or anti-CD33 mAbs. Thus, the present study suggests that p75/AIRM1 and CD33 may play a regulatory role in normal myelopoiesis and may be viewed as suitable target molecules to counteract the proliferation/survival of chronic myeloid leukemias.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-10358776, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-10499918, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-1374051, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-1711562, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-2147946, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-2469766, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-3390608, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-7718872, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-8306247, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-8627166, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-8717527, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-9143697, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-9465907, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-9626458, http://linkedlifedata.com/resource/pubmed/commentcorrection/10611343-9815888
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15091-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10611343-Antibodies, Monoclonal, pubmed-meshheading:10611343-Antigens, CD, pubmed-meshheading:10611343-Antigens, CD34, pubmed-meshheading:10611343-Antigens, Differentiation, Myelomonocytic, pubmed-meshheading:10611343-Cell Division, pubmed-meshheading:10611343-Cell Lineage, pubmed-meshheading:10611343-Culture Techniques, pubmed-meshheading:10611343-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:10611343-Hematopoietic Stem Cells, pubmed-meshheading:10611343-Hepatocyte Growth Factor, pubmed-meshheading:10611343-Humans, pubmed-meshheading:10611343-Immunologic Capping, pubmed-meshheading:10611343-Immunomagnetic Separation, pubmed-meshheading:10611343-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:10611343-Monocytes, pubmed-meshheading:10611343-Receptors, Immunologic
pubmed:year
1999
pubmed:articleTitle
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.
pubmed:affiliation
Istituto Nazionale per la Ricerca sul Cancro, 16132 Genova, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't